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SUMMARY: Obsessive-compulsive disorder (OCD) has been reported in association with some neurological diseases that affect the basal ganglia
such as Tourette’s syndrome, Sydenham’s chorea, Parkinson’s disease, and Huntington’s disease. Furthermore, studies such as neuroimaging, suggest a
role of the basal ganglia in the pathophysiology of OCD. The aim of this paper is to describe the association of OCD and several neurologic disorders
affecting the basal ganglia, report the existing evidences of the role of the basal ganglia in the pathophysiology of OCD, and analyze the mechanisms
probably involved in this pathophysiology.
DESCRIPTORS: Obsessive-compulsive disorder. Neuropsychiatry. Basal ganglia. Parkinson’s disease. Tourette’s syndrome. Sydenham’s
chorea. Huntington’s disease.
Although neurology and psychiatry
are generally defined as separate medi-
cal specialties, disorders affecting the
brain are not always restricted in clini-
cal expression to only one of these spe-
cialties. This is particularly true for dis-
orders affecting the basal ganglia, in
which the clinical picture is hardly ever
limited to symptoms classically de-
scribed as neurological or psychiatric.
For this reason, a current trend is to
describe these disturbances as neurop-
sychiatric.
Obsessive-compulsive disorder
(OCD) is one example of such a neu-
ropsychiatric disorder that has been the
object of growing interest in recent
years. It affects about 3% of the gen-
eral population1 and is the fourth most
frequent psychiatric diagnosis, sur-
passed only by phobias, depressions,
and drug addiction.1 OCD is character-
ized by obsessions and/or compulsions
that are intense enough to interfere in
the individual’s normal activities and in
his social relations. Obsessions are
characterized by thoughts, ideas, or
images (for example repetitive doubts
or thoughts about contamination) that
invade the individual’s awareness and
are distressing and persistent. Although
meaningless in themselves, the indi-
vidual recognizes the obsessions as the
product of his own mind and tries, al-
beit unsuccessfully, to extinguish them.
Compulsions are intentional repetitive
behaviors (for example, hand-washing
and rituals like checking doors and
windows, and so on) that are often car-
ried out in response to an obsession in
order to reduce or alleviate unpleasant
feelings 2.
OCD has recently been described
in association with basal-ganglia-re-
lated neurological diseases such as
Sydenham’s chorea3,4,5,6, Parkinson’s
disease7, and Huntington’s disease8. In
addition, Tourette’s syndrome also ap-
pears to be related to the basal ganglia,
and is often found in association with
OCD9,10,11.
The aim of this overview is to de-
scribe the current evidence of associa-
tion of OCD with several neurological
diseases primarily affecting the basal
ganglia, and to analyze the implica-
tions of these structures in the patho-
physiology of OCD.
OCD and Tourette’s syndrome
Tourette’s syndrome (TS) is a
chronic neuropsychiatric disorder char-
acterized primarily by the presence of
motor and vocal tics, defined as sud-
den, rapid, repetitive, stereotyped, in-
voluntary movements or vocalizations
that can be voluntarily suppressed,
even if only for a short period of time.
The tics often occur in bouts and tend
to become worse in moments of fatigue
and tension12.
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There is much evidence in favor of
an association between OCD and TS.
Gilles de la Tourette himself reported
obsessive-compulsive behaviors in the
cases he described in 1885. Several au-
thors have described a frequency of
obsessive-compulsive behavior in pa-
tients with TS greater than that found
in the general population9,10,11.
The association between OCD and
TS is also borne out in genetic studies.
Price et al.13, in a study of 43 pairs of
twins in which one member of each
pair presented TS, found obsessive-
compulsive symptoms in 83% of a to-
tal 86 individuals. These authors also
observed a greater frequency of obses-
sive-compulsive behavior among
monozygotic twins (52%) compared
with dizygotic twins (15%).
Pauls & Leckman14 found a greater
frequency of OCD in first-degree rela-
tives of TS patients, even in the ab-
sence of tics or TS, suggesting that cer-
tain forms of OCD could represent a
variant of the same genes related to TS.
Pauls et al.14, in a segregation analysis
study of 30 families, observed that the
spectrum of TS is inherited in accor-
dance with a dominant autosomal pat-
tern with sex-dependent variable pen-
etration.
Studies of patients with primary
OCD have also showed a high percent-
age of tics, ranging from 7% to 37%
15,16,17,11
. Rosário-Campos et al.18 as-
sessed 42 patients with OCD of whom
12 met criteria for a diagnosis of tics
and/or TS. Interestingly, tics and TS oc-
curred most frequently in the sub-group
presenting earlier onset of obsessive-
compulsive symptoms (before 10 years
of age) when compared with later-on-
set patients (after 18 years of age). Ad-
ditionally, tic-like compulsions were
more frequent in the early-onset group
than in the late-onset group (even in pa-
tients without a history of tics or TS).
These results suggest that early-onset
OCD is more related to the presence of
tics and TS than late-onset OCD.
Miguel et al.11,17 compared the char-
acteristics of the repetitive behavior in
patients with OCD +TS in relation to
a group of patients with OCD and
without tics or TS. It was observed that
in the patients with OCD + TS, the re-
petitive behaviors were less frequently
preceded by cognitions (obsessions)
and autonomic anxiety (e.g. dry mouth,
tachycardia, sweating, pallor, breath-
lessness) than in patients with OCD
without TS. Patients with OCD + TS
also presented a greater frequency of
sensory phenomena (e.g. sensations or
feelings of discomfort) preceding their
behaviors. Thus, patients with OCD
linked to TS also differ from those
without tics from a clinical point of
view, and it is believed that these vari-
ables may be important as predictive
factors for treatment. Finally, it should
be stressed that McDougle et al.19 have
recently shown that patients with OCD
+ tics do not respond satisfactorily to
classic treatment with selective seroto-
nin reuptake inhibitors, and that these
patients can benefit from the associa-
tion of these antidepressants with
neuroleptics. Summing up, there is a
fair amount of evidence in the litera-
ture suggesting a relationship between
OCD and TS. Genetic family studies
suggest that some forms of OCD may
be the expression of the same genes re-
lated to TS. Phenomenological studies
show that patients with OCD + TS ex-
hibit clinical features different from
those patients with OCD without tics
or TS. Early-onset OCD patients ap-
pear to have several characteristics in
common with patients with OCD + TS.
Finally, patients with OCD + TS also
appear to respond differently to com-
mon OCD treatments.
OCD and Sydenham’s chorea
Sydenham’s chorea (SC) is a disor-
der affecting the basal ganglia, charac-
terized by choreiform movements,
some degree of hypotonia and occa-
sionally by emotional instability. SC is
considered to be a complication of
rheumatic fever, and therefore arthritis
and carditis are other commonly asso-
ciated manifestations20.
The association between OCD and
SC was first established by Chapman3
in a study of 8 children with the dis-
ease, 4 of whom presented marked ob-
sessive-compulsive symptoms (OCS),
including washing rituals.
Grimshaw 4, on the other hand,
comparing the prevalence of neurologi-
cal alterations in patients with and
without obsessive characteristics,
found 6 with a history of SC out of 103
obsessive patients, whereas only 2 of
the 105 controls presented positive his-
tory for this condition.
In two studies, Swedo et al.5,6 de-
scribed interesting links between OCS
and SC. In the first5, children and ado-
lescents with previous history of SC
presented a greater prevalence of ob-
sessive-compulsive symptoms when
compared with a control group that had
had rheumatic fever (RF) without SC.
In the second study 6, 11 children in the
acute phase of SC were assessed in or-
der to detect obsessive-compulsive
symptomatology. Nine of them pre-
sented this type of psychiatric disorder
with acute onset; none of them had
previous history for OCS. Among these
9 children, 4 met criteria for OCD, 2
presented subclinical OCD, and 3 pre-
sented only OCS . The OCS began
shortly before the appearance of the
movement disorder, peaked during the
period of most intense choreiform
movements, and generally disappeared
before the movements did so.
Since the OCS in these children
with SC were identical to those in the
children with only OCD, Swedo et al.6
put forward the hypothesis that certain
cases of acute OCD in childhood might
represent an autoimmune cerebral dis-
order with similar mechanisms to SC,
even in the absence of RF. In other
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words, in genetically susceptible chil-
dren, infection by group A b hemolytic
streptococcus might induce the forma-
tion of antineuronal antibodies that in
certain subcortical structures might
lead to dysfunction of the basal gan-
glia. This dysfunction, in turn, might
manifest itself as SC, OCD, or both.
Mercadante et al.21 recently con-
cluded a study analyzing the preva-
lence of psychiatric disorders in 22 pa-
tients with RF and SC, 20 with RF but
without SC, and 20 controls. A greater
(but not statistically significant) fre-
quency of OCD was found in this study
in the two groups with RF when com-
pared with the control group. The fre-
quency of OCS in patients with only
RF was significantly greater when
compared with the control group; dif-
ferences between the groups with and
without SC with regard to OCD and
OCS were not observed. In the same
study, an increased frequency of tics
and attention deficit disorder with hy-
peractivity (ADDH) was found in pa-
tients with SC. Based on these results,
Mercadante et al.21 suggest a psycho-
pathological vulnerability in patients
with RF that manifests itself through a
symptomatological continuum includ-
ing OCS, ADDH, and movement dis-
orders such as tics and chorea.
In conclusion, there is evidence to-
day that OCD is not only more fre-
quent in patients with SC, but also in
patients with RF without SC, suggest-
ing that autoimmune mechanisms sec-
ondary to streptococcal infection could
play an important role in the etiology
of certain subtypes of OCD.
OCD and Parkinson’s disease
Parkinson’s disease (PD) is a
highly-prevalent neurological disorder.
Its major clinical features are akinesia,
plastic hypertonia, resting tremor, and
postural instability. Autonomic alter-
ations and psychiatric disorders such as
dementia and depression may also be
present. Prevalence ranges from 150 to
200 cases per 100,000 individuals in
the general population, increasing with
age so that the prevalence of PD in in-
dividuals over 65 is 1% 22.
The main pathophysiologic aspect
of PD is a decrease in dopaminergic lev-
els owing to degeneration of melanin-
containing neurons in the substantia ni-
gra (pars compacta), which are respon-
sible for production of this neurotrans-
mitter. These neurons project into the
striatum (caudate and putamen).
In the early twentieth century the
presence of OCD in cases of post-en-
cephalitic parkinsonism was ob-
served23. Lauterbach 24, studying 28
families with family Parkinsonism,
found a rate of OCD 5 times greater
than that of the normal population.
Tomer et al.7 recently carried out a
systematic study in 30 patients with
PD, showing that 17 of them presented
a total score for obsessive-compulsive
symptoms above that of the controls.
An association between motor asym-
metry and the presence of obsessive-
compulsive symptoms was observed in
this study. The intensity of the left-side
motor symptoms was associated with
cleanliness worries, repetitions, and
disturbing thoughts, whereas the sever-
ity of right-sided symptoms was sig-
nificantly related only to obsessions
with order and routine. Despite the fact
that some neuroimaging studies have
shown differences between the two
hemispheres 25,26,27,28, evidence regard-
ing lateralized pathophysiology in
OCD is inconclusive as yet.
In a preliminary analysis of a
prevalence study for OCS in patients
with Parkinson’s disease, Maia et al.29
found OCS in 12 (24%) of 50 patients
evaluated. This study also found a pre-
ponderance of left-side motor symp-
toms among patients with OCS, which
supports a hypothesis of a possible lat-
eralization in the pathophysiology of
OCD 30.
One should remember in analyzing
these results that Hardie et al.31 reported
that some patients after treatment with
levodopa began to present stereotyped
movements, even organized rituals,
suggesting that some patients with
OCS and Parkinson’s disease may suf-
fer their symptoms secondary to the
effect of the treatment given.
OCD and Huntington’s Disease
Huntington’s disease (HD) is a
dominant autosomal neurodegenerative
disease that primarily manifests itself
through choreiform movements and
progressive dementia. Although there
are few reports in the literature of OCD
in patients with HD, Cummings &
Cunningham 8 reported two cases of
HD with OCD appearing after the on-
set of the neurological symptoms of
HD. Fear of contamination and wash-
ing compulsion were present at first,
followed by a compulsion to smoke
and drink, without the characteristics
of dependency. According to the au-
thors, this scarcity of accounts may re-
flect either an actual low prevalence of
OCS in patients with HD, or a failure
to identify its manifestations, or even
a tendency for the manifestations to
appear late in the course of the disease,
when patients are presenting acute cog-
nitive disorders, making it difficult to
recognize the manifestations8.
OCD in other basal ganglia disorders
Obsessive-compulsive symptoms
have also been described in patients
with neuroacanthocytosis 32 and idio-
pathic spasmodic torticollis33.
Data from the literature also sug-
gest a relation between focal cerebral
lesions affecting the basal ganglia and
the appearance of obsessive-compul-
sive symptoms. Pulst et al.34 have de-
scribed OCS and tics in a patient with
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bilateral caudate lesions after carbon
monoxide poisoning. Weilburg et al.35
observed a patient with a history of
neonatal hypoxia and atrophy of the
left caudate and putamen who devel-
oped severe OCD in adolescence.
There are also accounts of OCD occur-
ring after bilateral caudate infarction
36,37,38
 and OCS after globus pallidus le-
sions caused by carbon monoxide poi-
soning 39,40 and post-anoxia 39.
The basal ganglia and the pathophy-
siology of OCD
The basal ganglia are deep subcor-
tical structures represented by the stria-
tum (caudate and putamen), globus
pallidus, substantia nigra, and the sub-
thalamic nucleus of Luys.
The anatomic connections of the
basal ganglia provide some evidence of
the participation of these structures in
non-motor functions. Of particular im-
portance are the connections between
the basal ganglia and the limbic sys-
tem. Many limbic projections into the
striatum are already known, mainly de-
riving from the hippocampus, cingulate
cortex, and amygdala. In addition to
the primary motor region, however,
other cortical regions – above all the
frontal cortex – send projections to the
basal ganglia.
In 1983, De Long et al.41 proposed
the existence of two loops involving
the basal ganglia. The motor loop, cen-
tered in the putamen, received afferent
projections from the sensory-motor
cortex and sent projections to the pre-
motor areas of the frontal cortex via the
globus pallidus and thalamus. The
complex loop, involving afferent pro-
jections from the associative areas of
the frontal cortex, projected into the
caudate nucleus and striatal–pallidal–
thalamic–cortical pathways towards the
prefrontal cortex.
According to studies by Alexander
et al.42, it is currently thought that five
parallel circuits exist that are respon-
sible for frontal-striatal connections:
the motor circuit, the oculomotor cir-
cuit, the dorsolateral prefrontal circuit,
the lateral orbitofrontal circuit, and the
anterior cingulate. Figure 1 shows
these circuits, except for the oculomo-
tor circuit, which is a variant of the
motor circuit.
Analyzing these frontal-striatal cir-
cuits, one can observe that cortical ar-
eas project with somatotypical organi-
zation into the striatum (putamen, cau-
date, and nucleus accumbens). These
projections are mediated by the exci-
tatory neurotransmitter glutamate. The
connections between the striatum and
the inner globus pallidus–substantia
nigra (pars reticulata) complex take
two pathways (Figure 2): the direct (in-
hibitory) pathway and the indirect
pathway, which goes through the exter-
nal globus pallidus and the subthalamic
nucleus of Luys (excitatory). Efferent
GABA-ergic projections leave the glo-
bus pallidus–substantia nigra complex
for the thalamus. Finally, thalamic nu-
clei (lateral ventral, anterior ventral,
and medial dorsal), establish feedback
loops by projecting into specific re-
gions of the frontal lobe. These
thalamo-cortical projections are be-
lieved to be excitatory and use aspar-
tate or glutamate as the neurotransmit-
ter.
The putamen, mainly associated
with motor aspects, and the caudate
and nucleus accumbens, related to cog-
nitive and behavioral aspects, can be
distinguished within the striatum.
However, given the overlap of differ-
ent cortical projections into the stria-
tum, this division should be considered
a continuous transition without defined
limits 43.
Other hypotheses relating to the or-
ganization of the striatum exist.
Graybiel et al.44,45 propose that the
striatum can be divided into two dis-
tinct compartments: the matrix, which
is mainly related to sensory-motor pro-
cessing, and the striosome, which re-
ceives afferent projections from struc-
tures associated with the limbic system
and associative areas. Both compo-
nents of the striatum, putamen and cau-
Figure 1 - Frontal-striatal connections.
DL: dorsolateral; DM: dorsomedial; VL: ventrolateral;
VA: ventroanterior; VM: ventromedial.
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date, contain matrix and striosomes.
This concept stemmed from studies
showing the presence of small acetyl-
cholinesterase-poor regions (strio-
somes) between acetylcholinesterase-
rich areas (matrix). These regions were
later found to differ with regard to sev-
eral other neurotransmitters45. The
striosome/matrix division is therefore
based on neurochemical data, while the
individuality of the caudate and puta-
men has an anatomic basis.
In addition to anatomic connec-
tions, neuroimaging studies have sug-
gested the participation of the basal
ganglia in the pathophysiology of
OCD. Several studies using both cra-
nial tomography and magnetic reso-
nance imaging have shown the loss of
the asymmetry normally observed in
caudate nuclei, the left being larger
than the right, in patients with OCD or
TS 25,26,27,28. On the other hand, other
authors have shown a reduction in size
of the lenticular nucleus (globus
pallidus and putamen) in magnetic
resonance imaging of patients with TS,
however without a change in the cau-
date volume46,47. The use of functional
neuroimaging enabled Baxter et al.48,49
to identify, through positron emission
tomography (PET-scan), an increase in
glucose metabolism in the caudate
nucleus and the orbitofrontal region of
patients with OCD, when compared to
controls. Later PET-scan studies 50 and
single-photon emission computed to-
mography (SPECT) studies 51 also
showed an increase of metabolic activ-
ity in the orbitofrontal region 51, and
Swedo et al.52 observed a correlation
between this increased activity and the
intensity of obsessive-compulsive
symptoms.
Functional neuroimaging studies of
patients with OCD before and after
treatment have shown interesting re-
sults. Baxter et al.48,53 observed a rela-
tion between decreased metabolic ac-
tivity of the caudate nucleus and im-
provement of symptoms after treat-
ment, and showed later that this de-
crease in metabolic activity of the head
of the caudate nucleus occurred not
only after pharmacologic treatment,
but also after behavioral psychothera-
peutic treatment. Benkelfat et al.54
found a decrease of metabolism of the
left caudate after treatment with clomi-
pramine. Swedo et al.55, also assessing
patients pre- and post-treatment,
showed a correlation between an in-
crease in activity in the right orbito-
frontal region and improvement in
symptoms after drug therapy. Based on
such data, Baxter et al.53 proposed a
hypothesis that there is an initial alter-
ation in the caudate and a later one in
the orbitofrontal region.
Interesting PET-scan analyses of
cerebral activity have been carried out
during provocation of obsessive-com-
pulsive symptoms. This provocation
was undertaken, for instance, in the
case of a patient with obsessions of
contamination, by wearing gloves pre-
viously contaminated by himself, in
comparison with a control state in
which the same patient wore sterile
gloves. Patterns of cerebral metabolic
activity consistent with other patterns
already alluded to – hyperactivity of
the caudate, thalamus and orbitofrontal
cortex – were found in these studies
56,57
. Rauch et al.56 have also observed
greater activity of the left anterior cin-
gulate cortex.
In addition to neuroimaging data,
the classic neuropsychological meth-
ods also bear out the hypothesis of the
participation of the basal ganglia in the
pathophysiology of OCD. One should
remember that neuropsychological al-
terations can sometimes be detected
even in the absence of a detectable
structural pathology 58.
Neuropsychological studies with
obsessive-compulsive patients have
shown similar results to those in pa-
tients with Parkinson’s or Huntington’s
disease. Studies of OCD have shown
impairment of visuospatial ability
59,60,61,62,
 non-verbal memory 61,63,64, and
executive functions 59,65,66,67,64.
Memory impairment seems to be
mainly linked to the implicit mecha-
nism of the memory. Storage and re-
call of this type of memory is not to-
tally dependent on awareness or cog-
Figure 2 - Corticostriate projections.
GP: globus pallidus; SN: substantia nigra; SNL: subthalamic nucleus
of Luys.
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nitive processes. It consists of a rela-
tively slow process that takes place
through repetition of tasks, and is char-
acterized by a performance improve-
ment in the execution of such tasks 68.
Alterations in implicit memory may
reflect a dysfunction of the striatum,
probably involved with this modality
of memory. Rauch et al.58 proposed
that the striatum carries out simpler
functions, facilitating good perfor-
mance of frontal cortex functions
(which are responsible for more com-
plex operations), in order to relieve it
of some portion of computational work
related primarily to processing uncon-
scious information. Some authors sug-
gest that impairment of executive func-
tions alters the planning, organization,
and ability to alter “patterns”, leading
to visuospatial and memory deficits.58.
On the basis of anatomic knowl-
edge and data obtained mainly through
neuroimaging studies, Baxter et al.53
have advanced a model that is interest-
ing with regard to the participation of
the basal ganglia in the pathophysiol-
ogy of OCD. According to their model,
the cortical-striatal-thalamic-cortical
circuits act as filters in order to inhibit
irrelevant thoughts.
According to this concept, a dys-
function of the caudate nucleus would
lead orbital cortex impulses not to be
suitably “filtered” (repressed), activat-
ing the direct pathway. Thus, the in-
hibitory impulses of the caudate over
the globus pallidus would increase.
This inhibition would result in less in-
hibition of the thalamus by the globus
pallidus, and consequently, excitatory
thalamic impulses to the orbital corti-
cal regions would make a reinforce-
ment loop. These changes would lead
to a failure to inhibit irrelevant worries,
which thus receive disproportional at-
tention (obsessions) and trigger repeti-
tive, senseless behaviors (compul-
sions).
Implications for the treatment of OCD
The knowledge acquired through
these studies stimulated proposals for
other OCD treatments. In addition to
the already existing pharmacologic ap-
proaches, such as the use of serotonin
reuptake inhibitors (SRIs), there are
surgical approaches, and most recently,
the emergence of repetitive transcranial
magnetic stimulation — rTMS.
With regard to surgical approaches,
recent studies suggest that several pro-
cedures (e.g. anterior cingulotomy, an-
terior capsulotomy, tractotomy of the
subcaudate, and limbic leukotomy)
may be effective in OCD cases refrac-
tory to usual treatment. Baer et al.69,70
have confirmed relative security and
effectiveness (around 30% of patients
presented marked improvements) in
the case of cingulotomy (stereotaxic
transection of the tracts from the fron-
tal cortex to subcortical sites – caudate)
as a treatment for patients with severe
OCD that is refractory to other forms
of treatment. Capsulotomy (lesion of
the internal capsule containing fibers
interconnecting the orbitofrontal region
and the dorso-medial nucleus of the
thalamus and other related areas) has
been performed in Europe for three de-
cades for refractory anxiety disorders.
A promising new technique is the
“gamma knife”, which makes a small
lesion in the anterior portion of the in-
ternal capsule 71. This procedure has
proved effective in a significant per-
centage of patients (around 60%), and
has advantages including the fact that
craniotomy is not necessary and that
the patient does not need a lengthy hos-
pital stay after the operation 71.
rTMS is a new non-invasive tech-
nique involving direct stimulation of
cortical neurons, which can cause al-
terations in cerebral activity, and can be
used for therapeutic purposes72. It is
believed that specific cerebral circuits,
such as those involved in OCD, can be
inhibited or stimulated by these tech-
niques. Greenberg et al.73 observed that
a single session of rTMS, aimed at the
right orbitofrontal cortex, produced a
reduction in compulsions for a roughly
8-hour period. The mechanisms by
which this technique benefited these
patients, however, need deeper study.
In conclusion, therefore, there is
evidence in favor of participation of the
basal ganglia in the pathophysiology of
OCD. These data have diagnostic and
therapeutic implications for the clini-
cal practice both of neurologists and
psychiatrists. In other words, in pa-
tients with OCD, the psychiatrist
should be aware that the presence of
other disorders involving the basal gan-
glia, such as Tourette’s syndrome,
Sydenham’s chorea, Huntington’s dis-
ease, and Parkinson’s disease may be
related to this disorder. Similarly, neu-
rologists should investigate obsessive-
compulsive symptoms when treating
patients with these diseases. Finally, it
is believed that a greater understanding
of the role of the basal ganglia in OCD
may be useful in developing new thera-
peutic approaches.
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O transtorno obsessivo-compulsivo
(TOC) tem sido reportado em associa-
ção com algumas doenças neurológicas
que afetam primariamente os gânglios
da base como a síndrome de Tourette ,
a coréia de Sydenham, a doença de
Parkinson e a doença de Huntington.
Da mesma forma, estudos de neuro-
imagem sugerem a participação dos
gânglios da base na fisiopatologia do
TOC. O objetivo deste estudo é rever
a coexistência de TOC e várias doen-
ças que afetam os gânglios da base, as
evidências da participação dessas estru-
turas na fisiopatologia do TOC e os
mecanismos neurais subjacentes a esse
distúrbio psiquiátrico.
DESCRITORES:  Transtorno
o b s e s s i v o - c o m p u l s i v o .
Neuropsiquiatria. Gânglios da base.
Doença de Parkinson. Síndrome de
Tourette. Coréia de Sydenham.
Doença de Huntington.
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